Insider Transactions in Q3 2024 at Incyte Corp (INCY)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
992
+0.01%
|
-
|
|
Sep 30
2024
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
378
+2.21%
|
$24,948
$66.1 P/Share
|
|
Sep 30
2024
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
368
+1.86%
|
$24,288
$66.1 P/Share
|
|
Sep 13
2024
|
Thomas Tray Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
382
-1.54%
|
$24,066
$63.37 P/Share
|
|
Sep 12
2024
|
Thomas Tray Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
572
-2.25%
|
$35,464
$62.94 P/Share
|
|
Sep 12
2024
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Open market or private sale
|
Direct |
8,450
-9.63%
|
$523,900
$62.33 P/Share
|
|
Aug 12
2024
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
11,608
-11.42%
|
$696,480
$60.63 P/Share
|
|
Jul 25
2024
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Open market or private sale
|
Direct |
15,571
-29.79%
|
$1,089,970
$70.0 P/Share
|
|
Jul 16
2024
|
Barry P Flannelly EVP & General Manager US |
SELL
Open market or private sale
|
Direct |
1,306
-2.2%
|
$83,584
$64.19 P/Share
|
|
Jul 15
2024
|
Paula J Swain EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
549
-0.63%
|
$35,136
$64.25 P/Share
|
|
Jul 15
2024
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
7,278
+7.75%
|
-
|
|
Jul 15
2024
|
Thomas Tray Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
466
-1.8%
|
$29,824
$64.25 P/Share
|
|
Jul 15
2024
|
Thomas Tray Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,073
+16.4%
|
-
|
|
Jul 15
2024
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,555
-1.51%
|
$99,520
$64.25 P/Share
|
|
Jul 15
2024
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,895
+11.87%
|
-
|
|
Jul 15
2024
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
948
-0.99%
|
$60,672
$64.25 P/Share
|
|
Jul 15
2024
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,572
+11.56%
|
-
|
|
Jul 15
2024
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Payment of exercise price or tax liability
|
Direct |
549
-1.04%
|
$35,136
$64.25 P/Share
|
|
Jul 15
2024
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
7,278
+12.11%
|
-
|
|
Jul 15
2024
|
Herve Hoppenot Chairman / CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,961
-0.99%
|
$317,504
$64.25 P/Share
|
|
Jul 15
2024
|
Herve Hoppenot Chairman / CEO |
BUY
Grant, award, or other acquisition
|
Direct |
41,025
+7.56%
|
-
|
|
Jul 15
2024
|
Pablo J Cagnoni President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
749
-0.34%
|
$47,936
$64.25 P/Share
|
|
Jul 15
2024
|
Pablo J Cagnoni President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
19,851
+8.21%
|
-
|
|
Jul 15
2024
|
Matteo Trotta EVP, GM, Dermatology US |
BUY
Grant, award, or other acquisition
|
Direct |
2,646
+20.17%
|
-
|
|
Jul 15
2024
|
Sheila A. Denton EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
5,955
+15.49%
|
-
|
|
Jul 15
2024
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
1,111
-1.84%
|
$71,104
$64.25 P/Share
|
|
Jul 15
2024
|
Barry P Flannelly EVP & General Manager US |
BUY
Grant, award, or other acquisition
|
Direct |
9,925
+14.1%
|
-
|
|
Jul 09
2024
|
Barry P Flannelly EVP & General Manager US |
SELL
Open market or private sale
|
Direct |
8,148
-13.89%
|
$488,880
$60.0 P/Share
|
|
Jul 02
2024
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
7,695
-11.59%
|
$454,005
$59.02 P/Share
|
|
Jul 02
2024
|
Herve Hoppenot Chairman / CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
41,723
-8.31%
|
$2,461,657
$59.02 P/Share
|
|
Jul 02
2024
|
Thomas Tray Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
844
-3.9%
|
$49,796
$59.02 P/Share
|
|
Jul 02
2024
|
Paula J Swain EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
5,560
-6.55%
|
$328,040
$59.02 P/Share
|
|
Jul 02
2024
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,316
-8.52%
|
$490,644
$59.02 P/Share
|
|
Jul 02
2024
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,870
-7.6%
|
$405,330
$59.02 P/Share
|
|
Jul 02
2024
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Payment of exercise price or tax liability
|
Direct |
5,706
-11.13%
|
$336,654
$59.02 P/Share
|